INCY.NASDAQIncyte CORP

Form 4: Incyte Director Paul J. Clancy Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Paul J. Clancy acquired 331 shares of Incyte stock and holds 19,713 shares, including unvested restricted stock units.

Summary

  • Paul J. Clancy, a director at Incyte Corp, reported a transaction involving the company's stock.
  • On December 31, 2024, Clancy acquired 331 shares of common stock at a price of $69.07 per share.
  • These shares were received as restricted stock in lieu of quarterly director retainer fees.
  • The restricted shares are fully vested.
  • Following this transaction, Clancy beneficially owns a total of 19,713 shares of Incyte stock.
  • This total includes 2,830 shares of common stock issuable from previously reported unvested restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing a stock transaction by a director. It does not contain any information that would significantly impact the sentiment of the stock.

Positives

  • The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It does not indicate any specific trend in the biotechnology industry.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies in the US, such as Incyte, and are required by the SEC to ensure transparency of insider trading.
  • Similar filings are made by directors and officers of comparable companies such as Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) when they engage in transactions involving their company's stock.
  • The number of shares acquired is relatively small compared to the total outstanding shares of Incyte, and is not unusual for director compensation.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it shows a director's continued investment in the company.

Key Dates

DateDescription
12/31/2024Date of the stock transaction where 331 shares were acquired.
01/03/2025Date the Form 4 was signed.

Keywords

Incyte, Director, Stock Transaction, Beneficial Ownership, Restricted Stock, Form 4, INCY

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.